“Safe Motherhood” Device Review Proposal Scheduled For July 31 Markup
This article was originally published in The Gray Sheet
Executive Summary
The range of medical devices that would be affected by the "Safe Motherhood Act for Research and Treatment Act" (S 2328) is attracting concern from some segments of the industry
You may also be interested in...
Orphan Device Funding Authorized By Energy & Commerce: $25 Mil. Per Year
The House Energy & Commerce Committee is authorizing additional funds for federal grants and contracts to develop devices and drugs for rare diseases
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.